Life Conflux
Comprehensive Journal Metrics & Impact Analysis
ISSN: 3078-4816 | Established 2024
📊 Journal Recognition & Standards
In 2024, Life Conflux achieved a significant milestone by receiving its International Standard Serial Number (ISSN) 3078-4816, marking its official recognition in the global academic publishing landscape.
As part of our commitment to advancing responsible research assessment practices, Life Conflux has implemented a comprehensive framework for transparent journal and article metrics. Our approach aligns with the San Francisco Declaration on Research Assessment (DORA) principles, emphasizing the importance of diverse evaluation criteria beyond traditional citation metrics.
"We believe that comprehensive metrics provide researchers, institutions, and funding bodies with a more nuanced understanding of research impact and journal quality, supporting evidence-based decision-making in academic publishing."
🎯 Understanding Journal Metrics Before Submission
Before submitting your manuscript to Life Conflux, we encourage researchers to familiarize themselves with the various metrics that reflect our journal's impact, reach, and editorial standards. These metrics serve multiple purposes:
Research Impact Assessment
Understand how your work will be evaluated within the broader scientific community and citation networks.
Publication Timeline
Plan your research dissemination strategy based on our efficient peer review and publication processes.
Global Accessibility
Leverage our open-access model to maximize the reach and impact of your research findings.
📈 Citation Impact Projections
Citation impact metrics measure the frequency with which articles published in Life Conflux are cited by other scholarly works. These projections are based on current submission quality, editorial standards, and the journal's growing reputation in interdisciplinary life sciences research.
⚠️ Future Projections: These metrics represent anticipated performance based on current editorial quality and submission trends.
2028 CiteScore (Scopus)
>10
Expected to rank in top 15% of life sciences journals
2028 Journal Citation Indicator
>4
Clarivate Web of Science category leadership
2028 Journal Impact Factor
>20
Targeting Q1 ranking in multiple disciplines
👥 Usage Analytics & Global Reach
Usage statistics provide valuable insights into the accessibility, popularity, and real-world impact of research published in Life Conflux. These metrics complement traditional citation measures by capturing immediate reader engagement and knowledge dissemination patterns.
2028 Projected Full Text Views
Annual downloads and online access statistics
Global Access Distribution: Our open-access model ensures worldwide availability, with projected readership spanning 150+ countries and supporting diverse research communities including those in developing nations.
⚡ Editorial Efficiency & Review Process
The efficiency of our editorial and peer review processes reflects our commitment to providing researchers with timely, constructive feedback while maintaining rigorous academic standards. Our streamlined workflow balances thoroughness with speed, respecting the urgency of scientific communication.
Acceptance Rate
21%
Selective standards ensuring high-quality publications
First Decision
19 days
Rapid initial review and editorial assessment
Acceptance Timeline
52 days
Complete peer review to final acceptance
Quality Assurance: Our editorial process includes initial screening, expert peer review, statistical review when applicable, and final editorial assessment to ensure all published work meets the highest scientific standards.
🧬 About Life Conflux
Life Conflux represents a pioneering approach to academic publishing in the life sciences and medical research domains. Our journal serves as a catalyst for interdisciplinary collaboration, bridging the gap between fundamental scientific discoveries and their practical applications in clinical settings and healthcare innovation.
Mission
Advance interdisciplinary frontiers and accelerate the translation of research into healthcare solutions.
Vision
Become the leading platform for transformative research that directly impacts human health and well-being.
Research Scope & Innovation Focus
Life Conflux particularly encourages submissions in cutting-edge areas that represent the future of life sciences and medical research:
Gene Editing & CRISPR Technologies
Therapeutic applications and ethical considerations
AI-Assisted Diagnostics
Machine learning in clinical decision-making
Personalized Medicine
Genomics-based treatment strategies
Regenerative Medicine
Stem cell therapy and tissue engineering
Life Conflux - Advancing the Future of Life Sciences Research
ISSN: 3078-4816 | Open Access | Peer Reviewed | International Editorial Board
Journal Information
- Journal: Life Conflux
- Online ISSN: 3078-4816
- Publisher: Life Conflux Press Limited
- Peer Review: Single-anonymous
- Publication Model: Open Access
- Publishing Frequency: Quarterly
- Languages: English
- DOI Prefix: 10.71321
Stay Updated
Subscribe to receive instant notifications when new articles, special issues, and important announcements are published.
Submit Your Research
Fast-track peer review process
Journal Metrics
Impact factors & citation analysis
Research Areas
Molecular Biology
Cell Biology
Neuroscience
Immunology
Genetics
Oncology
Cardiology
Biotechnology
And many more specialized fields within life sciences and medicine
For Authors & Reviewers
Publication Statistics
~28 days
Average Review Time
94%
Author Satisfaction
72%
Acceptance Rate
Global
Author Network
Open Access Benefits
✓
Immediate global accessibility
✓
No subscription barriers
✓
Enhanced citation potential
✓
Maximum research impact
Life Conflux promotes open science principles, ensuring that groundbreaking research in life sciences and medicine reaches the global scientific community without barriers, accelerating scientific discovery and innovation.
Creative Commons License
Life Conflux operates under a Creative Commons Attribution 4.0 International License, enabling unrestricted use, distribution, and reproduction while ensuring proper attribution to original authors and research integrity.
Copyright & Author Rights
Authors retain full copyright ownership of their work while granting Life Conflux the right to publish and distribute. All submissions must comply with our rigorous ethical standards and originality requirements. Published content becomes freely accessible to the global research community, promoting scientific advancement and knowledge sharing.
Key Requirements: Original research, ethical compliance, proper citations, and agreement to publication terms.
Publication Ethics
Life Conflux maintains the highest standards of publication ethics, preventing plagiarism, ensuring research integrity, and upholding international best practices. We implement comprehensive screening processes and follow COPE (Committee on Publication Ethics) guidelines to maintain scientific credibility.
Ethical Standards
COPE Certified
Digital Object Identifier
Every article receives a unique DOI through Crossref registration, ensuring permanent digital identification, reliable citation tracking, and long-term content preservation. This enhances discoverability and supports accurate academic referencing across global databases.
Recent Issues
